March 21 – 27 is National Drug & Alcohol Week
HINSDALE, Ill., March 16, 2022 /PRNewswire/ — Candor Health Education, a not-for-profit which provides drug, alcohol and sex education to Illinois students in grades four to eight, has launched a free, kid-friendly online game to provide teens and pre-teens tools for making healthy choices about drugs and alcohol. Called 'Pixelton Adventures,' the game features a Minecraft-style platform, allowing users to choose their own avatar and move through a series of daily decisions, challenges, and pressures, such as navigating friendships, balancing finals week, and managing extracurricular activities. With seven different episodes, Pixelton Adventures is free to students, but is also available at no cost to parents and teachers for use in conversations about drug and alcohol prevention.
The launch of Pixelton coincides with National Drug & Alcohol Facts Week, March 21-27, 2022. According to data released in November 2021 by the Centers for Disease Control, drug overdose deaths in the United States surpassed 100,000 in a 12-month period for the first time. The number of overdose deaths rose 29 percent, from 78,056 between April 2019 – April 2020, to 100,306 in the following 12 months. According to the National Center for Drug Abuse, 70% of people who try an illegal drug by age 13 will develop a substance abuse disorder.
Experts agree that education and prevention are key to reversing the trend.
"It is never too early to start conversations with children about drugs, alcohol, and the harm they can inflict," explains Katie Gallagher, Director of Education, Candor Health Education. "We are hopeful that Pixelton will provide a fun way for students to think through how they will navigate situations and challenges that could lead to drug and alcohol use.
A young person's brain changes rapidly during adolescence. During this time, the connections between neurons are strengthening and those that are unused go away. Chemical changes to the brain caused by drugs interfere with this process and can increase the likelihood of developing an addiction.
For more information on any of the Candor Health Education programs, visit www.candorhealthed.org or call Katie Gallagher, 630-325-1900.
View original content:https://www.prnewswire.com/news-releases/candor-health-education-launches-free-online-game-to-provide-kids-drug-and-alcohol-prevention-tools-301503799.html
SOURCE Candor Health Education
Shares of Incannex Healthcare (NASDAQ: IXHL) were crashing 58.4% lower as of 3:52 p.m. ET on Wednesday. The huge decline came after the Australian drugmaker announced earlier today the issuance of 1.85 million shares related to the exercise of unlisted stock options. The addition of 1.85 million shares makes up less than 4% of Incannex Healthcare's outstanding shares.
NLS Pharmaceutics Ltd (NASDAQ: NLSP) has announced interim topline data from its Phase 2a trial of its lead product candidate, Quilience (Mazindol ER), in narcolepsy. For excessive daytime sleepiness (EDS), the trial's primary endpoint, patients on Mazindol ER exhibited a mean decrease of 7.3 points on the sleepiness scale compared to a 3.0 point decrease for patients on placebo. Patients on Mazindol ER showed a mean 39% improvement on the sleepiness scale from baseline. To date, Mazindol ER was
"I always felt like I had something to prove."
When most companies spotlight record revenue growth, that means they’ve sold more product than ever before. But for pharmaceutical companies, that isn’t necessarily the case.
Pfizer and its partner BioNTech asked U.S. regulators Tuesday to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggests older adults would benefit. Currently the U.S. urges two primary shots followed months later by a booster dose for everyone age 12 and older. The Food and Drug Administration and the Centers for Disease Control would have to approve the request.
Shares of Biogen Inc. gained 4.3% in premarket trading on Wednesday after the company announced new data for its Alzheimer's disease drug demonstrating reductions in amyloid beta plaques for 132 weeks and plasma p-tau181 for 128 weeks. The company also said in a news release that the clinical-trial data show that patients with lower plasma p-tau181 levels had less clinical decline. Adoption of Aduhelm has been low since it was approved in June. The drug generated $3 million in the six months of
Because, unfortunately, nature does not cure disease, even though the words of French philosopher and historian Voltaire would have you believe otherwise: "The art of medicine consists of amusing the patient while nature cures the disease," Voltaire had once famously said. TheStreet has compiled a list of some of the most expensive drug treatments in the world that cure diseases ranging from progeria, when infants start to look elderly to spinal muscular atrophy, neuroblastoma and a rare blood disorder. Swiss pharmaceutical giant Novartis apparently sells the most expensive drug in the world that costs $2.1 million.
Alector Inc (NASDAQ: ALEC) is flashing some AL001 (latozinemab) Phase 2 data at an Alzheimer’s and Parkinson’s disease conference, this time in dementia with a different type of mutation: C9orf72. Results in this cohort also showed elevated progranulin levels in both plasma and cerebrospinal fluid while patients were on monthly treatment for a year. Additionally, clinical assessments showed a delay in annualized disease progression, approximately 54%. Related: Alector Stock Falls After Flashing
Patients who received Biogen's Alzheimer's drug for over two years showed slower cognitive decline — leading Biogen stock to tick higher.
Health insurers that sell private Medicare plans collected $12 billion more caring for seniors in 2020 than it would have cost in traditional Medicare, according to a report from the Medicare Payment Advisory Commission.It shows the need for major payment reforms, according to the report.Get market news worthy of your time with Axios Markets. Subscribe for free.Why it matters: Overpaying the Medicare Advantage plans as their enrollment continues to grow threatens Medicare's long-term finances.De
As most start to restart daily life, experts worry COVID-19 may not be done yet and one company says a fourth shot may be needed.
Vladimir Putin’s mental state is “normal”, the Kremlin insisted on Wednesday, amid rumours that the Russian president may be suffering from an illness or even an addiction to steroids.
The disinfectant is commonly used to clean fish tanks
Windtree Therapeutics Inc (NASDAQ: WINT) has completed enrollment in its phase 2 study of istaroxime in early cardiogenic shock caused by heart failure. The study enrolled 60 patients with severe heart failure and systolic blood pressure (SBP) between 75 and 90 mmHg. The study drug was administered over 24 hours. The primary endpoint is the SBP profile over the first 6 hours after initiating the infusion. Secondary endpoints will include various assessments of blood pressure changes over 24 hour
Wastewater samples — which can predict when COVID-19 infections will increase — show that U.S. cases are rising again
Just as mandates end and more people are taking off their masks, another COVID variant is spreading, causing cases to rise around the world.
The research will focus on treating a recurrence of prostate cancer, for which there is just a 29% survival rate
SEOUL (Reuters) -South Korea recorded a record 621,328 new daily COVID-19 cases and a daily record 429 deaths, authorities said on Thursday, as the country which once took an aggressive anti-pandemic approach is set to end COVID restrictions. The Korea Disease Control and Prevention Agency said the highly infectious Omicron variant was driving the record wave of infections and while a public survey revealed many expected to catch the virus, few feared serious health consequences. On Wednesday the government said it expected the wave to top out with daily cases in the mid-400,000.
‘I’m not sure people appreciate quite how bad the Covid situation is in Hong Kong, nor what might be around the corner’
Health care stocks represent the only defensive sector that is also relatively immune to inflationary risks.